Skip to content
Homepage
Author:
Tempest Therapeutics
Posted Date:
June 4, 2026
Tempest Therapeutics Appoints Drake Richey and John Yee, MD, MPH to Board of Directors
Tempest Therapeutics
June 4, 2026
Tempest Therapeutics Announces Warrant Exercise for Approximately $2 Million in Gross Proceeds
Tempest Therapeutics
May 29, 2026
Tempest Reports First Quarter 2026 Financial Results and Provides Business Update
Tempest Therapeutics
May 14, 2026
Tempest Presents Clinical Update at ISCT 2026 Annual Meeting
Tempest Therapeutics
May 6, 2026
Tempest to Advance Dual-Targeting CAR-T Platform with Clinical Update at ISCT 2026 Annual Meeting
Tempest Therapeutics
May 3, 2026
1
2
3
Next
